Logopenic aphasia due to Lewy body disease dramatically improved with donepezil

Logopenic aphasia due to Lewy body disease dramatically improved with donepezil

•Pathological basis of primary progressive aphasia is heterogeneous.•Logopenic primary progressive aphasia can precede dementia with Lewy bodies (DLB).•Cholinesterase inhibitor can improve logopenic aphasia with DLB.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:eNeurologicalSci 2020-06, Vol.19, p.100241, Article 100241
Hauptverfasser: Kakinuma, Kazuo, Baba, Toru, Ezura, Michinori, Endo, Keiko, Saito, Yumiko, Narita, Wataru, Iizuka, Osamu, Nishio, Yoshiyuki, Kikuchi, Akio, Hasegawa, Takafumi, Aoki, Masashi, Suzuki, Kyoko
Format: Artikel
Sprache:eng
Schlagworte:
Alzheimer's disease
Case Report
Cholinesterase inhibitor
Lewy body disease
Logopenic aphasia
Primary progressive aphasia
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•Pathological basis of primary progressive aphasia is heterogeneous.•Logopenic primary progressive aphasia can precede dementia with Lewy bodies (DLB).•Cholinesterase inhibitor can improve logopenic aphasia with DLB.
ISSN:2405-6502
2405-6502
DOI:10.1016/j.ensci.2020.100241